Key points are not available for this paper at this time.
Figure S2. Change from baseline in tumor size and tuvusertib dose levels (FAS/SAF Analysis Set)
Yap et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: